Back to results

Treatment of pregnant women affected with polycystic ovary syndrome

Patent Application number: European Procedure (Patents) (EPA) - 31 Mars 2017 - 17 305 385.1
Inventors:
GIACOBINI PaoloPREVOT Vincent
Publications:
Tata B Mimouni NEH Barbotin AL Malone SA Loyens A Pigny P Dewailly D Catteau-Jonard S Sundström-Poromaa I Piltonen TT Dal Bello F Medana C Prevot V Clasadonte J and Giacobini P (2018) Elevated prenatal anti-Müllerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood. Nature Medicine. DOI: 10.1038/s41591-018-0035-5.

Reference:

BIO17095-T1

    Business Developper
    contact
    Inserm Transfert
    Business Developer
    Patent filling date: 31-03-2017
    Rare disease: No
    Second indication: No

    You might also be interested in